Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 14 items for :

  • Pasireotide-LAR x
Clear All
Hélène Lasolle Fédération d’Endocrinologie, Centre de Référence Maladies Rares Hypophysaires HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France

Search for other papers by Hélène Lasolle in
Google Scholar
PubMed Close
,
Amandine Ferriere Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Amandine Ferriere in
Google Scholar
PubMed Close
,
Alexandre Vasiljevic Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France
Centre de Pathologie et de Neuropathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France

Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed Close
,
Sandrine Eimer UFR Sciences médicales, Université de Bordeaux, Bordeaux, France
Service d’anatomo-pathologie, Hopital Pellegrin, CHU de Bordeaux, Bordeaux, France

Search for other papers by Sandrine Eimer in
Google Scholar
PubMed Close
,
Marie-Laure Nunes Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France

Search for other papers by Marie-Laure Nunes in
Google Scholar
PubMed Close
, and
Antoine Tabarin Service d’endocrinologie, diabète et nutrition, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France

Search for other papers by Antoine Tabarin in
Google Scholar
PubMed Close

. Pasireotide-LAR is a multireceptor-targeted somatostatin analog with superior clinical efficacy over octreotide-LAR ( 9 ) that can control GH and IGF-1 concentrations in patients resistant to 1gSRL ( 10 ). Consequently, it is approved for treatment of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0332
Volume/Issue:
Volume 8: Issue 10
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
Liliya Rostomyan Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Liliya Rostomyan in
Google Scholar
PubMed Close
,
Daniela Betea Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Daniela Betea in
Google Scholar
PubMed Close
,
Jean-François Bonneville Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Jean-François Bonneville in
Google Scholar
PubMed Close
,
Chiara Villa Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium
Department of Pathological Cytology and Anatomy, Foch Hospital, Paris, France

Search for other papers by Chiara Villa in
Google Scholar
PubMed Close
,
Natalia S Pellegata Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany

Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed Close
,
Beatrice Waser Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Beatrice Waser in
Google Scholar
PubMed Close
,
Jean-Claude Reubi Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Jean-Claude Reubi in
Google Scholar
PubMed Close
,
Catherine Waeber Stephan Clinique Générale Ste-Anne, Fribourg, Switzerland

Search for other papers by Catherine Waeber Stephan in
Google Scholar
PubMed Close
,
Emanuel Christ Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, University of Basel, Basel, Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed Close
, and
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire (CHU) de Liège, Liège Université, Domaine Universitaire du Sart-Tilman, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close

and HbA1c levels are shown in response to octreotide/lanreotide depots and then with pasireotide LAR beginning in 2006, until withdrawn 18 months ago. The normal range for IGF-1 is outlined in grey in the lower part of the graph. The postoperative

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0004
Volume/Issue:
Volume 8: Issue 4
Open access
Peter Wolf Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

Search for other papers by Peter Wolf in
Google Scholar
PubMed Close
,
Alexandre Dormoy Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed Close
,
Luigi Maione Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Luigi Maione in
Google Scholar
PubMed Close
,
Sylvie Salenave Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Sylvie Salenave in
Google Scholar
PubMed Close
,
Jacques Young Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Jacques Young in
Google Scholar
PubMed Close
,
Peter Kamenický Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Peter Kamenický in
Google Scholar
PubMed Close
, and
Philippe Chanson Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close

randomized, open-label, phase IV study . Pituitary 2021 24 887 – 903 . ( https://doi.org/10.1007/s11102-021-01161-4 ) 30 Coopmans EC Muhammad A van der Lely AJ Janssen JAMJL Neggers SJCMM . How to position pasireotide LAR treatment in acromegaly

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0296
Volume/Issue:
Volume 11: Issue 12
Open access
Nelma Veronica Marques Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed Close
,
Luiz Eduardo Armondi Wildemberg Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed Close
, and
Monica R Gadelha Neuroendocrinology Research Center, Endocrinology Section, Medical School and Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Monica R Gadelha in
Google Scholar
PubMed Close

to starting pasireotide, × ULN Completed clinical trial 1 38 M N Y N Octreotide LAR + cabergoline 1.9 CSOM230C2402 ( 7 ) 2 54 F N N N Octreotide LAR 3.0 CSOM230C2402 ( 7 ) 3 33 M Y N N

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0155
Volume/Issue:
Volume 12: Issue 10
Open access
Mônica R Gadelha Endocrine Unit, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close
,
Feng Gu Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Beijing, China

Search for other papers by Feng Gu in
Google Scholar
PubMed Close
,
Marcello D Bronstein Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School, São Paulo, Brazil

Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed Close
,
Thierry C Brue Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale, Marseille Medical Genetics, and Assistance Publique Hôpitaux de Marseille, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l’Hypophyse, Marseille, France

Search for other papers by Thierry C Brue in
Google Scholar
PubMed Close
,
Maria Fleseriu Northwest Pituitary Center, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Maria Fleseriu in
Google Scholar
PubMed Close
,
Ilan Shimon Institute of Endocrinology and Metabolism, Rabin Medical Center, and Sackler School of Medicine, Tel-Aviv University, Petah-Tiqva, Israel

Search for other papers by Ilan Shimon in
Google Scholar
PubMed Close
,
Aart J van der Lely Erasmus University Medical Center, Rotterdam, The Netherlands

Search for other papers by Aart J van der Lely in
Google Scholar
PubMed Close
,
Shoba Ravichandran Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA

Search for other papers by Shoba Ravichandran in
Google Scholar
PubMed Close
,
Albert Kandra Recordati AG, Basel, Switzerland

Search for other papers by Albert Kandra in
Google Scholar
PubMed Close
,
Alberto M Pedroncelli Recordati AG, Basel, Switzerland

Search for other papers by Alberto M Pedroncelli in
Google Scholar
PubMed Close
, and
Annamaria A L Colao Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy

Search for other papers by Annamaria A L Colao in
Google Scholar
PubMed Close

levels and (B) mean HbA 1c after crossover in study C2305. Numbers below the horizontal axes refer to numbers of patients who crossed over to long-acting pasireotide/crossed over to long-acting octreotide. HbA 1c , glycated hemoglobin; LAR, long

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0361
Volume/Issue:
Volume 9: Issue 12
Open access
Bernardo Maia Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Bernardo Maia in
Google Scholar
PubMed Close
,
Leandro Kasuki Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil

Search for other papers by Leandro Kasuki in
Google Scholar
PubMed Close
, and
Mônica R Gadelha Neuroendocrinology Research Center/Endocrinology Division – Medical School and Hospital Universitário Clementino Fraga Filho – Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil

Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed Close

-acting release (OCT-LAR) and lanreotide autogel, that are considered first-line therapy; and second-generation SRL, represented by pasireotide (PAS) ( 13 ). Both fg-SRLs, in real-life, seem to be equally effective in controlling GH and IGF-I levels in

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0433
Volume/Issue:
Volume 9: Issue 12
Open access
Julie M Silverstein Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8127, St Louis, Missouri 63110, USA

Search for other papers by Julie M Silverstein in
Google Scholar
PubMed Close

Biopharmaceuticals Inc, Basking Ridge, NJ, USA), and pasireotide LAR are the currently available SSAs approved by the Food and Drug Administration for the treatment of patients with acromegaly (32, 33, 34, 35) . Approximately 50% of patients with acromegaly achieve

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-15-0064
Volume/Issue:
Volume 4: Issue 4
Open access
Jonathan Hazlehurst Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed Close
,
Bernard Khoo Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Bernard Khoo in
Google Scholar
PubMed Close
,
Carolina Brito Lobato Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark

Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed Close
,
Ibiyemi Ilesanmi Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed Close
,
Sally Abbott Department of Dietetics, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Sally Abbott in
Google Scholar
PubMed Close
,
Tin Chan Faculty of Medicine, Chinese University of Hong Kong, Hong Kong

Search for other papers by Tin Chan in
Google Scholar
PubMed Close
,
Sanesh Pillai Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

Search for other papers by Sanesh Pillai in
Google Scholar
PubMed Close
,
Kate Maslin School of Nursing and Midwifery, University of Plymouth, Plymouth, UK

Search for other papers by Kate Maslin in
Google Scholar
PubMed Close
,
Sanjay Purkayastha Brunel University, London, UK
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK

Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed Close
,
Barbara McGowan Endocrinology, Guys’ and St Thomas’s NHS Foundation Trust, London, UK

Search for other papers by Barbara McGowan in
Google Scholar
PubMed Close
,
Rob Andrews University of Exeter Medical School, Exeter, UK

Search for other papers by Rob Andrews in
Google Scholar
PubMed Close
,
Eveleigh Nicholson Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed Close
,
Katherine McCullough Royal Surrey County Hospital, Guildford, UK

Search for other papers by Katherine McCullough in
Google Scholar
PubMed Close
,
Lorraine Albon University Hospitals Sussex NHS Foundation Trust, Worthing, UK

Search for other papers by Lorraine Albon in
Google Scholar
PubMed Close
,
Rachel Batterham Endocrinology, Division of Medicine, University College London, London, UK

Search for other papers by Rachel Batterham in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis King's College Hospital NHS Foundation Trust, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Shareen Forbes BHF Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK

Search for other papers by Shareen Forbes in
Google Scholar
PubMed Close
,
Gavin Bewick School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Search for other papers by Gavin Bewick in
Google Scholar
PubMed Close
, and
Tricia M-M Tan Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK

Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed Close

-acting SC pasireotide or octreotide (given three times a day before meals) or long-acting IM pasireotide LAR. Moderate 3.3 Diazoxide may be considered as a third-line option if somatostatin analogues are not tolerated. Low 3.4 In people

Article Type:
Other
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0285
Volume/Issue:
Volume 13: Issue 5
Open access
Adrian F Daly Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Adrian F Daly in
Google Scholar
PubMed Close
,
David A Cano Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by David A Cano in
Google Scholar
PubMed Close
,
Eva Venegas-Moreno Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Eva Venegas-Moreno in
Google Scholar
PubMed Close
,
Patrick Petrossians Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Patrick Petrossians in
Google Scholar
PubMed Close
,
Elena Dios Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Elena Dios in
Google Scholar
PubMed Close
,
Emilie Castermans Department of Human Genetics, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Emilie Castermans in
Google Scholar
PubMed Close
,
Alvaro Flores-Martínez Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Alvaro Flores-Martínez in
Google Scholar
PubMed Close
,
Vincent Bours Department of Human Genetics, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Vincent Bours in
Google Scholar
PubMed Close
,
Albert Beckers Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Liège, Belgium

Search for other papers by Albert Beckers in
Google Scholar
PubMed Close
, and
Alfonso Soto-Moreno Unidad de Gestión de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

Search for other papers by Alfonso Soto-Moreno in
Google Scholar
PubMed Close

adenomas were significantly more frequent in the low AIP-IHC group. Sparsely granulated adenomas have previously been shown to be associated with lower responses to octreotide/lanreotide and better responses to pasireotide and they predominate in AIP mut

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0027
Volume/Issue:
Volume 8: Issue 4
Open access
Kosmas Daskalakis Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Kosmas Daskalakis in
Google Scholar
PubMed Close
,
Marina Tsoli 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Marina Tsoli in
Google Scholar
PubMed Close
,
Anna Angelousi 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Angelousi in
Google Scholar
PubMed Close
,
Evanthia Kassi 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Evanthia Kassi in
Google Scholar
PubMed Close
,
Krystallenia I Alexandraki 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed Close
,
Denise Kolomodi 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Denise Kolomodi in
Google Scholar
PubMed Close
,
Gregory Kaltsas 1st Department of Propaupaedic Internal Medicine, Endocrine Unit, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry, UK
Centre of Applied Biological & Exercise Sciences, Faculty of Health & Life Sciences, Coventry University, Coventry, UK

Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed Close
, and
Anna Koumarianou Haematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Anna Koumarianou in
Google Scholar
PubMed Close

or combined with SSAs) was similar to prior reports of everolimus monotherapy and a recent phase II trial on everolimus and octreotide LAR combination in gastroenteropancreatic NENs (EVERLAR trial), suggesting that prompt management of everolimus SE

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0134
Volume/Issue:
Volume 8: Issue 6
Open access